Asana Insider Filing Shows Routine 13k-Share RSU Grant to Director
Rhea-AI Filing Summary
Asana, Inc. (ASAN) – Form 4 insider filing dated 06/18/2025
Director Krista Anderson-Copperman reported the award of 13,089 Restricted Stock Units (RSUs) on 06/16/2025. Each RSU converts into one share of Class A common stock upon settlement. The grant vests 100% on the earlier of June 16, 2026 or the date of the next annual shareholders’ meeting, contingent on continued service. Following the award, the director’s total beneficial ownership stands at 62,710 shares, all held directly. No cash consideration was paid (exercise price $0), and no derivative securities were involved.
The disclosure represents a standard equity-based compensation grant under Asana’s director compensation program; it does not reflect an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insights
TL;DR – Routine director RSU grant; neutral governance impact.
The filing records a single RSU award to an outside director, typical for mid-cap tech compensation programs. At ~0.01% of Asana’s basic share count, the dilution effect is immaterial. Because the award vests in one year and requires board service, it aligns director incentives with shareholders without triggering cash outflows. No buy/sell signals arise, so the market impact should be negligible.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 13,089 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents the grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. 100% of the RSUs will vest on the earlier of June 16, 2026 or the day of the next annual meeting of the stockholders, subject to the Reporting Person's continuous service through such date.
FAQ
What is the vesting schedule for the 13,089 RSUs reported by ASAN?
What is Krista Anderson-Copperman’s total beneficial ownership after the grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.